OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of the Metabolic Characteristics of Newer Second Generation Antipsychotics
J Gréger, Traci Aladeen, Emily Lewandowski, et al.
Journal of Clinical Psychopharmacology (2020) Vol. 41, Iss. 1, pp. 5-12
Closed Access | Times Cited: 18

Showing 18 citing articles:

An Evaluation of Iloperidone for Mania in Bipolar I Disorder
Kelen Caskey, Leigh Anne Nelson
Annals of Pharmacotherapy (2025)
Closed Access

Antipsychotic-Induced Weight Gain: What Have We Learned?
Anne M. Silas, Maurizio Musso, Trygve Dolber
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Open Access

Alterações metabólicas decorrentes da utilização de Brexpiprazol: uma breve revisão sistemática
Laíse Maria Barbosa Amaral, T Paiva, Isabela de Nazaré Tavares Cardoso Souza, et al.
Caderno Pedagógico (2025) Vol. 22, Iss. 5, pp. e14629-e14629
Closed Access

The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats
Srinivas Kamath, Alexander Hunter, Kate Collins, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 22, pp. 4531-4545
Open Access | Times Cited: 3

The atypical antipsychotic lurasidone positively modulates the gut microbiota in rats: A comparative study to olanzapine
Srinivas Kamath, Alexander Hunter, Kate Collins, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Sensory evaluation of the bitterness of asenapine using D-sorbitol pretreatment: single-blind, placebo-controlled, crossover trial
Shuhei Wada, Kunihiro Iwamoto, Hiroki Okumura, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4

Cariprazine in the management of emotionally unstable personality disorder in female patients: a case series
Sofia Pappa, Ellice Caldwell-Dunn, Arturas Kalniunas, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1

Changes in Metabolic Parameters and Body Weight in Patients With Prediabetes Treated With Adjunctive Brexpiprazole for Major Depressive Disorder
John W. Newcomer, Stine R. Meehan, Dalei Chen, et al.
The Journal of Clinical Psychiatry (2023) Vol. 84, Iss. 5
Open Access | Times Cited: 2

Features of Clinical Use of Brexpiprazole, the New Atypical Antipsychotic of the Third Generation: Experience and Perspectives
И. В. Олейчик, T. I. Shishkovskaya, P A Baranov, et al.
Psikhiatriya (2022) Vol. 20, Iss. 3, pp. 134-142
Open Access | Times Cited: 3

The effect of differences in trial design on estimates of efficacy of olanzapine in randomized studies.
Francesco Rotella, Andrea Falone, Emanuele Cassioli, et al.
Psychiatry Research (2024) Vol. 336, pp. 115895-115895
Open Access

ANTIPSYCHOTIC DRUGS: THREE GENERATIONS OF ANTIPSYCHOTICS
S. G. Sukiasyan
ARMENIAN JOURNAL OF MENTAL HEALTH (2024), pp. 3-26
Closed Access

Antipsychotika
Matthias J. Müller, Otto Benkert
Springer eBooks (2023), pp. 283-488
Closed Access | Times Cited: 1

Autism Spectrum Disorder
Donald E. Greydanus, Dilip R. Patel, Dustin C. Rowland
Elsevier eBooks (2021), pp. 396-434
Closed Access | Times Cited: 1

Korean Medication Algorithm Project for Bipolar Disorder 2022: Comorbid Physical Illnesses
Myung Hun Jung, Won‐Myong Bahk, Young Sup Woo, et al.
Journal of Korean Neuropsychiatric Association (2022) Vol. 61, Iss. 4, pp. 267-267
Open Access

Psychopharmacology
Benoit H. Mulsant, Bruce G. Pollock
American Psychiatric Association Publishing eBooks (2022)
Closed Access

Lurasidone in the treatment of pharmacoresistant schizophrenia: a case report
Jan Hubeňák
Psychiatrie pro praxi (2021) Vol. 22, Iss. 3, pp. 163-166
Closed Access

Page 1

Scroll to top